Travere Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $12M | 405k | 29.72 |
| 2025-12-31 | $15M | 395k | 38.21 |
| 2025-09-30 | $1.9M | 79k | 23.90 |
| 2025-06-30 | $1.1M | 71k | 14.81 |
| 2025-03-31 | $956k | 53k | 17.93 |
| 2024-12-31 | $690k | 40k | 17.42 |
| 2024-09-30 | $3.9M | 281k | 13.99 |
| 2024-06-30 | $275k | 33k | 8.22 |
| 2024-03-31 | $240k | 31k | 7.74 |
| 2023-12-31 | $253k | 28k | 9.02 |
| 2023-09-30 | $240k | 27k | 8.94 |
| 2023-06-30 | $571k | 37k | 15.37 |
| 2023-03-31 | $704k | 31k | 22.50 |
| 2022-12-31 | $610k | 29k | 21.04 |
| 2022-03-31 | $425k | 17k | 25.78 |
| 2021-12-31 | $441k | 14k | 31.06 |